Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health

NCT05160220 is registered in ClinicalTrials.gov with National Council of Scientific and Technical Research, Argentina as lead sponsor.

NCT NCT05160220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health
Lead sponsor
National Council of Scientific and Technical Research, Argentina
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2021
Completion date
October 1, 2021
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, creativity, mood change, sleep